Updated Feb. 6, 2013 at 9:29 a.m.
Andrew Witty discusses "change program." (GSK photo)
Research Triangle Park, N.C. — GlaxoSmithKline Chief Executive Officer Andrew Witty is speeding up cost-cutting at the drug giant through what he describes as a "change program." As profits plunge and the drug industry continues to change, GSK must change as well, he explains.
Call it 'change' if you like, but GSK CEO is making 'cuts'
Post a comment
Print this blog postE-mail blog post
Share
Andrew Witty discusses "change program." (GSK photo)
Research Triangle Park, N.C. — GlaxoSmithKline Chief Executive Officer Andrew Witty is speeding up cost-cutting at the drug giant through what he describes as a "change program." As profits plunge and the drug industry continues to change, GSK must change as well, he explains.
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire. All rights reserved.Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
The Skinny
WRAL Local Tech Wire Publisher and Editor Rick Smith dishes out tidbits from the local technology sector. Read more articles…
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Raleigh-based PRA International eyes public offering- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows
- Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
- Triangle politician tries to accelerate crowdfunding; bill passes first hurdle
- ChannelAdvisor seeks $80M, sets share target price for IPO
- IT job openings 28% below 2012 numbers, report shows